Clinical Programs

Heart disease remains the number one killer in the United States and millions of patients continue to suffer from chronic heart disease. These patients face limited therapeutic options and little chance for meaningful clinical improvement. Aastrom is developing Cardiac Repair Cells (CRCs), based on TRC technology, with the goal of repairing and regenerating damaged heart tissue in patients with severe chronic diseases.